Ovodan Biotech A/S: Financial statements 2022
CVR: 33870256
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Ovodan Biotech A/S (CVR 33870256) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -439,188 and a net result of DKK -1,530,961 compared with DKK -1,973,294 the year before. Equity in the 2022 report amounted to DKK -20,726,686. The company had 3 employees in the financial year.
- Gross Profit
- DKK -439,188
- Profit/Loss
- DKK -1,530,961
- Equity
- DKK -20,726,686
- Total Assets
- DKK 1,786,591
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -439K | -1.5M | -20.7M | 3 |
| 2021 | - | -741K | -2M | -19.2M | 3 |
| 2020 | - | -1.5M | -3.1M | -17.2M | 5 |
| 2019 | - | -1.8M | -2.9M | -14.1M | 4 |
| 2018 | - | -720K | -2.6M | -11.1M | 4 |
Official annual report
Keep an eye on Ovodan Biotech A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Ovodan Biotech A/S has published its annual report for 2021. Gross profit came to DKK -741,245, and the net result was DKK -1,973,294.
About Ovodan Biotech A/S
Ovodan Biotech A/S is a Danish company of the type Aktieselskab based in Odense C, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SANOVO BIOTECH A/S. The management consists of Henrik Marinus Pedersen. The board consists of Thor Stadil (chair), Christian Nicholas Rosenkrantz Stadil and Henrik Marinus Pedersen. The company is owned by Ovodan Foods A/S. The company has 0 employees (2012). In 2025, the company reported a gross profit of DKK -805,830 and a net result of DKK -1,201,387 compared with DKK -1,177,651 the year before. Equity in the 2025 report amounted to DKK -884,888.